Studying Microglia as Possible Therapeutic Targets for Autism Spectrum Disorder (ASD) in a Mouse Model of Maternal Anti Caspr2 Antibody-Induced ASD
Abstract
Our studies use a model in which in utero exposure to maternal anti-Caspr2 antibody affects microglial maturation program, possibly arresting microglial development in male, but not female mice, leading to of Autism Spectrum Disorder (ASD)-like phenotype. We also study if we can ameliorate the ASD-like phenotype by suppressing microglial activation using an FDA approved drug.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2023
- Accession Number
- AD1216509
Entities
People
- Lior Brimberg
Organizations
- The Feinstein Institute for Medical Research